{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:41:39Z","timestamp":1777876899383,"version":"3.51.4"},"reference-count":92,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2015,8,30]],"date-time":"2015-08-30T00:00:00Z","timestamp":1440892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Musculoskeletal"],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:p>Systemic lupus erythematous (SLE) is a chronic multisystem disease with significant associated morbidity and mortality. A deeper understanding of the pathogenesis of SLE has led to the development of biologic agents, primarily targeting B cells and others inhibiting costimulatory molecules, type I interferons and cytokines such as interleukin-6. Several of these agents have been studied in clinical trials; some have shown promise while others have yielded disappointing results. Economic and regulatory issues continue to hamper the availability of such therapies for SLE patients. With increasing recognition that recurrent flares of disease activity lead to long-term damage accrual, one of the most important recent developments in patient management has been the concept of treat-to-target in SLE while minimizing patient exposure to excessive corticosteroid and other immunosuppressive therapy. This article reviews these key issues in SLE management, outlining recent developments and clinical implications for patients.<\/jats:p>","DOI":"10.1177\/1759720x15601805","type":"journal-article","created":{"date-parts":[[2015,8,31]],"date-time":"2015-08-31T20:39:26Z","timestamp":1441053566000},"page":"234-246","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Key issues in the management of patients with systemic lupus erythematosus: latest developments and clinical implications"],"prefix":"10.1177","volume":"7","author":[{"given":"Natasha","family":"Jordan","sequence":"first","affiliation":[{"name":"Addenbrooke\u2019s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"D\u2019Cruz","sequence":"additional","affiliation":[{"name":"Louise Coote Lupus Unit, Guys Hospital, London, SE1 9RT, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2015,8,30]]},"reference":[{"key":"bibr1-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.09.034"},{"key":"bibr2-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206016"},{"key":"bibr3-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0337679100"},{"key":"bibr4-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1191\/096120300674499064"},{"key":"bibr5-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021553"},{"key":"bibr6-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1002\/art.21955"},{"key":"bibr7-1759720X15601805","author":"Bruce I.","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"bibr8-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1038\/328267a0"},{"key":"bibr9-1759720X15601805","author":"Burton M.","year":"2015","journal-title":"The Rheumatologist"},{"key":"bibr10-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.097972"},{"key":"bibr11-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.079418"},{"key":"bibr12-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq256"},{"key":"bibr13-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S"},{"key":"bibr14-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-007-9104-0"},{"key":"bibr15-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1002\/art.22025"},{"key":"bibr16-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1186\/ar1855"},{"key":"bibr17-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202844"},{"key":"bibr18-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1002\/art.20147"},{"key":"bibr19-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.5.2913"},{"key":"bibr20-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1002\/art.23047"},{"key":"bibr21-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep012"},{"key":"bibr22-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1186\/ar3397"},{"key":"bibr23-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.10.009"},{"key":"bibr24-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1186\/ar2959"},{"key":"bibr25-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1186\/ar1942"},{"key":"bibr26-1759720X15601805","unstructured":"Eli Lilly and Company (2014) Lilly to discontinue development of tabalumab based on efficacy results in phase 3 lupus studies. Press release, 2 October 2014. Available from: https:\/\/investor.lilly.com\/releasedetail.cfm?ReleaseID=874281 (accessed 5 August 2015)."},{"key":"bibr27-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1126\/science.7520604"},{"key":"bibr28-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314524292"},{"key":"bibr29-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1002\/art.38260"},{"key":"bibr30-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1002\/art.30613"},{"key":"bibr31-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes072"},{"key":"bibr32-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1186\/ar3738"},{"key":"bibr33-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1038\/35010115"},{"key":"bibr34-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1159\/000334955"},{"key":"bibr35-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197907053010102"},{"key":"bibr36-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1002\/art.27221"},{"key":"bibr37-1759720X15601805","author":"Isenberg D.","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"bibr38-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.075762"},{"key":"bibr39-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909169"},{"key":"bibr40-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/91.6.393"},{"key":"bibr41-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2012-007834."},{"key":"bibr42-1759720X15601805","first-page":"L4","volume":"66","author":"Khamashta M.","year":"2014","journal-title":"Arthritis Rheum"},{"key":"bibr43-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1038\/ng2091"},{"key":"bibr44-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2006.02433.x"},{"key":"bibr45-1759720X15601805","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4049\/jimmunol.147.1.117","volume":"147","author":"Linker-Israeli M.","year":"1991","journal-title":"J Immunol"},{"key":"bibr46-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1002\/art.24341"},{"key":"bibr47-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e31823ecd73"},{"key":"bibr48-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.2.168"},{"key":"bibr49-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1002\/art.34632"},{"key":"bibr50-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(55)90018-7"},{"key":"bibr51-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1002\/art.27601"},{"key":"bibr52-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1002\/art.27233"},{"key":"bibr53-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.144485"},{"key":"bibr54-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1998.00612.x"},{"key":"bibr55-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5425.260"},{"key":"bibr56-1759720X15601805","first-page":"719","volume":"66","author":"Morehouse C.","year":"2014","journal-title":"Arthritis Rheum"},{"key":"bibr57-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.528"},{"key":"bibr58-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00280.x"},{"key":"bibr59-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61354-2"},{"key":"bibr60-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2015.1007810"},{"key":"bibr61-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp336"},{"key":"bibr62-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1177\/096120339600500603"},{"key":"bibr63-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1002\/art.23678"},{"key":"bibr64-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1002\/art.37824"},{"key":"bibr65-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket284"},{"key":"bibr66-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610313351807"},{"key":"bibr67-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2933"},{"key":"bibr68-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70258-8"},{"key":"bibr69-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1990.tb00144.x"},{"key":"bibr70-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-3-178"},{"key":"bibr71-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098315"},{"key":"bibr72-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-12-473744"},{"key":"bibr73-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1002\/art.34359"},{"key":"bibr74-1759720X15601805","first-page":"927","volume":"144","author":"Ryffel B.","year":"1994","journal-title":"Am J Pathol"},{"key":"bibr75-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1007\/BF02788753"},{"key":"bibr76-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.11.1747"},{"key":"bibr77-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201310"},{"key":"bibr78-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1186\/ar2976"},{"key":"bibr79-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909905"},{"key":"bibr80-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1002\/art.27541"},{"key":"bibr81-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1126\/science.1061965"},{"key":"bibr82-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1159\/000045663"},{"key":"bibr83-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-205139"},{"key":"bibr84-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200937"},{"key":"bibr85-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket129"},{"key":"bibr86-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202760"},{"key":"bibr87-1759720X15601805","unstructured":"Wallace D., Popa S., Spindler A. (2014b) Improvement of disease activity and reduction of severe flares following subcutaneous administration of an IL-6 monoclonal antibody (mAb) in subjects with active generalized systemic lupus erythematosus (SLE). ACR abstract."},{"key":"bibr88-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu393"},{"key":"bibr89-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1002\/art.37940"},{"key":"bibr90-1759720X15601805","first-page":"38","volume":"111","author":"Yang G.","year":"1998","journal-title":"Chin Med J (Engl)"},{"key":"bibr91-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780250407"},{"key":"bibr92-1759720X15601805","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202460"}],"container-title":["Therapeutic Advances in Musculoskeletal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1759720X15601805","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1759720X15601805","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1759720X15601805","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:35:44Z","timestamp":1777588544000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1759720X15601805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,30]]},"references-count":92,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.1177\/1759720X15601805"],"URL":"https:\/\/doi.org\/10.1177\/1759720x15601805","relation":{},"ISSN":["1759-720X","1759-7218"],"issn-type":[{"value":"1759-720X","type":"print"},{"value":"1759-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,30]]}}}